Pain
Video
CGRP drugs: How is it going?
STOWE, VT. – Dr. Peter McAllister summarizes postmarketing experiences with CGRP monoclonal antibodies for migraine prevention.
Conference Coverage
Opioid overdose risk greater among HIV patients
Video
MS research: “Our patients can’t wait” for conventional techniques
DALLAS – Harnessing big data helps with precision assessment of MS phenotype.
Conference Coverage
Migraine associated with more severe disability in patients with MS
DALLAS – “Traditional migraine risk factors such as obesity, anxiety, and depression were also overrepresented in our cohort” of patients with MS...
Literature Review
International survey probes oxygen’s efficacy for cluster headache
Oxygen is a highly effective therapy with few complications, according to a survey of patients with cluster headache.
From the Journals
In California, opioids most often prescribed in low-income, mostly white areas
Opioid-related overdose deaths are highest in low-income white areas.
From the Journals
Cloud of inconsistency hangs over cannabis data
Number of medical cannabis users is up more than 10-fold since 2009, available data show.
From the Journals
Compounded pain creams no better than placebo creams in localized chronic pain
At 1 month, creams specifically formulated for neuropathic, nociceptive, or mixed pain had no effect beyond placebo.
From the Journals
Age of migraine onset may affect stroke risk
One unexpected finding was that the onset of migraine with aura before age 50 is not associated with ischemic stroke.
From the Journals
Study hints at lacosamide’s efficacy for small fiber neuropathy
First study of lacosamide for Nav1.7-related small fiber neuropathy shows promise.
News from the FDA/CDC
FDA labeling templates smooth way for OTC naloxone
The templates aim to ease the submission process for manufacturers.